HK1250944A1 - 用於治療癌症的方法 - Google Patents

用於治療癌症的方法

Info

Publication number
HK1250944A1
HK1250944A1 HK18110438.9A HK18110438A HK1250944A1 HK 1250944 A1 HK1250944 A1 HK 1250944A1 HK 18110438 A HK18110438 A HK 18110438A HK 1250944 A1 HK1250944 A1 HK 1250944A1
Authority
HK
Hong Kong
Prior art keywords
methods
treating cancer
cancer
treating
Prior art date
Application number
HK18110438.9A
Other languages
English (en)
Inventor
Chiang J Li
Wei Li
Youzhi Li
Matthew J Hitron
Yuan Gao
Original Assignee
Boston Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Biomedical Inc filed Critical Boston Biomedical Inc
Publication of HK1250944A1 publication Critical patent/HK1250944A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18110438.9A 2015-04-17 2018-08-14 用於治療癌症的方法 HK1250944A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562149349P 2015-04-17 2015-04-17
US201662280947P 2016-01-20 2016-01-20
PCT/US2016/028177 WO2016168856A1 (en) 2015-04-17 2016-04-18 Methods for treating cancer

Publications (1)

Publication Number Publication Date
HK1250944A1 true HK1250944A1 (zh) 2019-01-18

Family

ID=55854799

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110438.9A HK1250944A1 (zh) 2015-04-17 2018-08-14 用於治療癌症的方法

Country Status (16)

Country Link
US (1) US20180085341A1 (zh)
EP (1) EP3283069A1 (zh)
JP (1) JP2018511643A (zh)
KR (1) KR20180006918A (zh)
CN (1) CN107666906A (zh)
AU (1) AU2016247319A1 (zh)
BR (1) BR112017022281A2 (zh)
CA (1) CA2983010A1 (zh)
EA (1) EA201792287A1 (zh)
HK (1) HK1250944A1 (zh)
IL (1) IL255022A0 (zh)
MX (1) MX2017013360A (zh)
PH (1) PH12017501879A1 (zh)
SG (2) SG10201900564WA (zh)
TW (1) TW201713327A (zh)
WO (1) WO2016168856A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009036059A2 (en) 2007-09-10 2009-03-19 Boston Biomedical, Inc. Novel stat3 pathway inhibitors and cancer stem cell inhibitors
BR112015025347A2 (pt) 2013-04-09 2017-07-18 Boston Biomedical Inc 2-acetil-nafto [2-3-b] furan-4,9-diona para uso no tratamento do câncer
CA3011800A1 (en) * 2016-01-20 2017-08-03 Boston Biomedical, Inc. Methods for treating cancer
JP7106563B2 (ja) 2016-11-29 2022-07-26 スミトモ ファーマ オンコロジー， インコーポレイテッド ナフトフラン誘導体、その調製、および使用方法
WO2018213424A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer
JP7399079B2 (ja) * 2017-09-05 2023-12-15 エピザイム，インコーポレイティド 癌を処置するための併用療法
SG11202103707TA (en) * 2018-10-12 2021-05-28 1Globe Biomedical Co Ltd New combination solution for treating chemotherapy refractory cancer
TW202102207A (zh) * 2019-03-27 2021-01-16 新加坡商新加坡保健服務集團有限公司 對於癌病具有治療意義的生物標記

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009036059A2 (en) * 2007-09-10 2009-03-19 Boston Biomedical, Inc. Novel stat3 pathway inhibitors and cancer stem cell inhibitors
MX370721B (es) 2010-03-19 2019-12-20 Boston Biomedical Inc Star Compuestos y composiciones novedosas para atacar las células madre del cáncer.
JP2013522326A (ja) 2010-03-19 2013-06-13 ボストン バイオメディカル， インコーポレイテッド がん幹細胞を標的とするための新規の方法
EP2681203A4 (en) 2011-03-04 2014-07-30 Zhoushan Haizhongzhou Xinsheng Pharmaceuticals Co Ltd NOVEL 4,9-DIHYDROXY-NAPHTO [2,3-B] FURANS ESTERS FOR THERAPEUTIC TREATMENT OF DISEASES
US8977803B2 (en) 2011-11-21 2015-03-10 Western Digital Technologies, Inc. Disk drive data caching using a multi-tiered memory
WO2013166618A1 (en) * 2012-05-08 2013-11-14 Zhoushan Haizhongzhou Xinsheng Pharmaceuticals Co., Ltd. PRODRUGS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR CIRCUMVENTING CANCER MULTIDRUG RESISTANCE
BR112015025347A2 (pt) * 2013-04-09 2017-07-18 Boston Biomedical Inc 2-acetil-nafto [2-3-b] furan-4,9-diona para uso no tratamento do câncer

Also Published As

Publication number Publication date
CA2983010A1 (en) 2016-10-20
WO2016168856A1 (en) 2016-10-20
IL255022A0 (en) 2017-12-31
KR20180006918A (ko) 2018-01-19
BR112017022281A2 (pt) 2018-07-10
JP2018511643A (ja) 2018-04-26
SG10201900564WA (en) 2019-02-27
PH12017501879A1 (en) 2018-03-05
TW201713327A (zh) 2017-04-16
EP3283069A1 (en) 2018-02-21
SG11201708504XA (en) 2017-11-29
US20180085341A1 (en) 2018-03-29
MX2017013360A (es) 2018-08-01
EA201792287A1 (ru) 2018-03-30
CN107666906A (zh) 2018-02-06
AU2016247319A1 (en) 2017-11-02

Similar Documents

Publication Publication Date Title
HK1251407A1 (zh) 治療癌症的方法
ZA201706616B (en) Method for treating cancer
IL304252A (en) Cancer treatment methods
IL289947A (en) A method for treating cancer
HK1249469A1 (zh) 用RORγ抑制劑治療癌症的方法
HUE059694T2 (hu) Készítmény rák kezelésére
IL257691A (en) A method for treating cancer
HK1254258A1 (zh) 使用阿吡莫德治療癌症的方法
HK1244217A1 (zh) 用於治療蛋白質病的方法
EP3389634A4 (en) METHOD FOR THE TREATMENT OF CANCER
HK1250944A1 (zh) 用於治療癌症的方法
EP3389652A4 (en) METHODS OF TREATING CANCER
IL255079A0 (en) Methods of treating lung cancer
HK1248135A1 (zh) 用於治療癌症的聯合方法
HK1250942A1 (zh) 用於治療癌症的方法
IL246558A0 (en) New methods of cancer treatment
HK1250943A1 (zh) 用於治療癌症的方法
SG10201508795XA (en) Method for treating cancer
HK1256371A1 (zh) 用於治療腫瘤的方法